LESS TEP vs. Three Port TEP for Inguinal Hernia Repair

June 17, 2023 updated by: Sofia Med Hospital

Laparoendoscopic Single-site Versus Three Port Totally Extraperitoneal Hernia Repair: A Prospective Double Blinded Randomized Clinical Trial

This study aim to compare efficacy and safety of Laparoendoscopic single site total extraperitoneal inguinal hernia repair /LESS TEP/ and traditional total extraperitoneal hernia repair with 3 ports /TEP/.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

This is a prospective, double blinded, randomized trial. It compared of Laparoendoscopic single site total extraperitoneal inguinal hernia repair /LESS TEP/ and traditional total extraperitoneal hernia repair with 3 ports /TEP/.

Inguinal hernia is one of the most common surgical diseases. Laparoscopic hernia repairs include two types, TEP and TAPP. Laparoscopic inguinal hernia repair was associated with less post operative pain, a shorter recovery period and better cosmetic results. Efforts are continuing to further reduce the port related morbidities and improve the cosmetic outcomes of laparoscopic surgery, including reduction of the size and number of ports. This has led to the evolution of a novel surgical approach now collectively known as laparoendoscopic single-site surgery.

200 patients will undergo TEP inguinal hernia repair. They will be randomized in two groups by sealed envelope method.

Group A: Standard TEP with 3 ports (10mm. and 2 ports of 5mm.). In case of difficulty in Standard 3 port TEP inguinal hernia repair, the procedure will be converted to TAPP.

Group B: LESS TEP with single skin incision 2-3cm. In case of difficulty in LESS TEP inguinal hernia repair, the procedure will be converted to standard 3 port repair or TAPP.

Patient will be informed at consenting that 3 wound plasters will be applied to their abdomen regardless of whether they are in the single port or 3- ports group so that they would not know which group they have been randomized to. The blind will only be lifted after pain score and area of pain has been recorded before discharge.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sofia, Bulgaria
        • Sofiamed Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 18 and 90 years
  • Willing to participate in this study and signed an informed consent.
  • Diagnosed inguinal hernia - primary or recurrence
  • ASA class I, II and III

Exclusion Criteria:

  • Age under 18 years and above 90 years
  • Strangulated hernia
  • Patients with severe chronic diseases or cardiopulmonary dysfunction, who can't undergo general anesthesia
  • Patients who prefer a certain surgical approach
  • Patients who undergo surgery procedures for chronic pain after inguinal hernia repair

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard 3 port TEP
Group A will undergo laparoscopic TEP inguinal hernia repair with 3 ports (10 mm , and 2 ports of 5 mm ).
3 port TEP inguinal hernia repair with 10mm. port under the umbilicus and two 5mm. port in line under the 10mm. port
Active Comparator: LESS TEP
Group B will undergo laparoscopic TEP inguinal hernia repair with a single skin incision 2-3cm.
TEP inguinal hernia repair with one vertical skin incision under the umbilicus

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain
Time Frame: 24hours
Assessment of post-operative pain according to the visual analog scale pain score - From 0 to 10 - 0 is no pain and 10 is severe pain.
24hours
Postoperative Pain
Time Frame: 1 week
Assessment of post-operative pain according to the visual analog scale pain score - From 0 to 10 - 0 is no pain and 10 is severe pain.
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operating time
Time Frame: During operation
During operation
Intraoperative complications
Time Frame: During operation
Assessment of interoperation procedure of the incident of spermaduct, vessel and other organ damage
During operation
Length of hospital stay
Time Frame: 24 hours
24 hours
Postoperative complications
Time Frame: 1 week; 4 weeks
Urinary infections; Seroma; Hematoma
1 week; 4 weeks
Recurrence of hernia
Time Frame: 4 weeks; 3 months; 1 year
4 weeks; 3 months; 1 year
Cosmetic scar score
Time Frame: 4 weeks
Scar evaluation using Patient and Observer Scar Assessment Scale (POSAS) 4 week after the surgery
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2020

Primary Completion (Actual)

January 1, 2021

Study Completion (Estimated)

July 31, 2024

Study Registration Dates

First Submitted

February 26, 2020

First Submitted That Met QC Criteria

March 8, 2020

First Posted (Actual)

March 10, 2020

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 17, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 204 (Fakultät für Psychologie Ethikkommission, Ruhr University of Bochum)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inguinal Hernia

Clinical Trials on Standard 3 port TEP

3
Subscribe